IntroductIon In the pathogenesis of diffuse parenchymal lung diseases (DPLDs), growth factors, including transforming growth factor β 1 (TGF-β 1 ), are responsible for cell proliferation, apoptosis, chemotaxis, and angiogenesis, and also for the production and secretion of some components of the extracellular matrix.
IntroductIon Diffuse parenchymal lung diseases (DPLDs) are a heterogeneous group characterized by progressive dyspnea, the presence of diffuse reticular markings on the chest X-ray, and restrictive impairment in pulmonary function tests. DPLDs include not only diseases of known etiology, such as collagenosis or occupational exposure, but also idiopathic inter stitial pneumonias (IIP) and a large group of granulomatous diseases (GD), such as sarcoidosis, extrinsic allergic alveolitis (EAA), and rare histiocytosis X or lymphangioleiomyomatosis.
In the pathogenesis of DPLDs, especially of inter stitial pulmonary fibrosis (IPF), growth orIGInAL ArtIcLE TGF-β 1 in bronchoalveolar lavage fluid in diffuse parenchymal lung diseases and high-resolution computed tomography score
The aim of the study was to assess correlations between TGF-β 1 levels in bronchoalveolar lavage (BAL) fluid in DPLD patients and the activity of changes assessed by HRCT score.
PAtIEnts And mEthods A group of consecutive patients with suspected DPLD were included in the study. The final diagnosis had not been established prior to inclusion despite the clinical and radio logical findings (especially HRCT) and the use of minimally invasive methods (e.g., transbronchial lung bio psy). In all patients, antinuclear and antineutrophil cytoplasmic antibodies were negative. Patients' general condition allowed to perform video-assisted thoracic surgery (VATS) lung bio psy under general anesthesia (American Society of Anesthesio logists, 1-3).
Only 1 patient with sarcoidosis had diabetes, and 2 patients from the IIP and GD groups had arterial hypertension and ischemic heart disease (tAbLE 1).
Exclusion criteria were as follows: a radio logical pattern of opacities typical for sarcoidosis or IIP, diagnosis of connective tissue disease, general status that excluded VATS, and lack of informed consent.
HRCT of the lungs was performed using the spiral HeliCAT Twin Flash (Elscint, Israel) with the Indy workstation (Silicon-Graphics, United States) and the software (OmniPro, United States). The HRCT score was calculated according to the Bergin and Remy-Jardin criteria.
7,8 For each slice, as well as for the whole lung and individual factors play a key role. They include transforming growth factor β (TGF-β), platelet-derived growth factor, insulin-like growth factor, and tumor necrosis factor, which are responsible for cell proliferation, apoptosis, chemotaxis, and angiogenesis, and also for the production and secretion of some components of the extracellular matrix. The most important is TGF-β produced by a variety of cells, including platelets, neutrophils, eosinophils, fibroblasts, and endothelial cells. In the study conducted by Smith et al. 1 TGF-β protein level was 11-fold higher in IPF patients compared with normal control lungs. A substantial body of evidence suggests that TGF-β is a critical cytokine that promotes pulmonary fibrosis. In IPF patients, TGF-β levels correlate with mortality.
2 A predominant isoform of TGF-β in IPF is TGF-β 1 .
In the diagnosis of IPF, high-resolution computed tomography (HRCT) plays an important role. HRCT sensitivity in the diagnosis of IPF is estimated at 86%, 3 but the final diagnosis of a DPLD should be based on clinical features, radiological findings, and patho logical evaluation of the bio psy specimen. [4] [5] [6] The distribution of diffuse parenchymal opacities in DPLDs is usually nonhomogenous -the areas of active inflammation and fibrosis may be adjacent to normal lung parenchyma. The HRCT score is a semiquantitative method of the overall assessment of distribution and type of diffuse opacities. It enables to determine the areas of the highest and lowest intensity of abnormalities and possible correlations with the levels of growth factors. For patho logical examination, the standard hematoxylin-eosin stained, para ffin-embedded tissue blocks were used. The analysis was performed independently by 2 patho logists; neither of them was informed about the radio logical findings nor the results of HRCT score.
The study was approved by the Bioethical Committee of the Jagiellonian University, Kraków, Poland. All patients received detailed information regarding the procedures; also, their potential risks and benefits were discussed. Informed consent was obtained from all patients.
statistical analysis Statistical analysis was performed using the Statistica TM software (Statsoft Inc., United States). Summary statistics were expressed as mean, standard deviation, median, as well as 25% and 75% percentiles. The Student's t-test with separate estimation of variances was used for preliminary group comparison. The general linear model for response variables, including qualitative and quantitative variables and their inter actions, was also used. The Tukey's test was used for multiple comparisons. The level of significance was set at P ≤0.05.
rEsuLts Based on clinical and radio logical findings and histo logical results of VATS lung biopsy, the diagnosis was established in all 31 patients. Histo logical examination of lung specimens alone enabled to establish a definitive diagnosis in 83.9% of patients. Based on histopathology, the patients were classified into 2 groups: IIP and GD. The IIP group included 17 patients: usual inter stitial pneumonia (UIP) -12, nonspecific inter stitial pneumonia (NSIP) -2, cryptogenic organizing pneumonia (COP) -2, and desquamative inter stitial pneumonia (DIP) -1. The GD group included 14 patients: sarcoidosis -7, EAA -5, and histiocytosis X -2. In 3 patients with homogenous distribution on HRCT, histiocytosis X -1, UIP -1, and COP -1 were diagnosed.
Comorbidities did not affect TGF-β 1 levels in the studied patients. A smoking history correlated with higher TGF-β 1 levels (P = 0.042, analysis of variance [ANOVA] ). There was no association between TGF-β 1 and age (P = 0.630, ANOVA) or sex (P = 0.936, ANOVA) (tAbLE 1).
lung segments, the semiquantitative assessment for the following types of opacities was performed: 1) nodular, 2) linear, 3) ground-glass, and 4) consolidations. The HRCT score was complemented by semiquantitative assessment of additional categories: 5) horizontal distribution pattern, 6) lobular distribution, 7) grade of intensity of diffuse opacities, and 8) activity of diffuse opacities (tAbLE 2). The HRCT score for the whole lungs was calculated as the sum of all scores of 22 to 26 slices divided by the maximal possible score; the result was expressed as a percentage. The HRCT score for individual segments was calculated in the same way. The most involved (high; sA) and the least involved (low; sB) segments on the same side were determined. The HRCT score was independently calculated by 2 radio logists.
BAL was performed according to the American Thoracic Society quidelines, 9 under mild intravenous sedation with midazolam (1-5 mg i.v.) and fentanyl (0.05-0.1 mg i.v.), using the IT160 videobronchoscopes (Olympus Medical Systems Corporation, Tokyo, Japan). All patients received oxygen through a nose catheter, and saturation and heart rate were monitored using a pulsoximeter during bronchoscopy.
In patients with nonhomogenous distribution of changes in HRCT score, BAL was performed from segments sA and sB. The tip of the bronchofiberoscope was wedged in the chosen segment, and 4 portions of saline (50 ml each) were instilled. After instillation, the saline was gently sucked and collected in silicone container. Supernatant obtained after centrifugation was stored in -70°C.
TGF-β 1 levels in BAL fluid were measured by an enzyme immunoassay using commercial kits ("sandwich" ELISA, R&D Systems, Quntikine®, Human TGF-β 1 , United States).
VATS lung bio psy was taken from the segments chosen using the above-mentioned criteria and was performed under general anesthesia with double-lumen intubation. The standard video equipment was used (light source Quantum 3000 and video-camera 784, Stryker, United States with monitor PVM 204 3MD, Sony, Japan) and rigid 9 mm thoracoscope 30°, (Storz, Germany). The bio psies were performed using the EndoGia universal staplers (Tyco, United States). 
We also found that TGF-β 1 levels in BAL fluid were similar between the groups, although there was a trend towards higher levels in the IIP group. Similarly, Meloni et al. 16 showed no differences in TGF-β levels in patients with scleroderma-associated inter stitial lung disease, IPF, and sarcoidosis compared with healthy subjects. Also Salez et al. 17 showed normal TGF-β 1 levels in sarcoidosis and healthy volunteers. Limper et al. 18 observed that TGF-β 1 may play an important role in the synthesis of some compounds of the extracellular matrix, especially fibronectin and fibronectin receptor α5b1, and not only in IPF, but also in noncaseating granulomas, which implies that TGF-β 1 might modulate the mechanisms of repair and fibrosis in patients with sarcoidosis. These reports suggest that TGF-β 1 may not be a specific marker for any inter stitial lung disease. [15] [16] [17] 19 Higher levels of TGF-β in IPF patients were found not only in lung bio psies, but also in BAL fluid. 20 Continuous mRNA expression of TGF-β 1 in alveolar macrophages may be responsible for higher TGF-β 1 levels in IPF patients. 21 Some authors attempted to assess the factors that may activate TGF-β, such as thrombospondin 1 (TSP-1). Ide et al. 22 reported increased levels of TSP-1 in serum and BAL fluid in IIP patients.
22
However, the role of TSP-1 in the pathogenesis of IIP requires further investigation.
A number of studies assessed the role of genetic factors in the pathogenesis of IPF. Xaubet et al. 23 showed that TGF-β 1 polymorphism does not predispose to the development of IPF, but may play an important role in the progression of the disease. TGF-β may also influence the prognosis of inter stitial lung diseases. Hiwatari et al. 24 demonstrated that the elevated levels of TGF-β in IPF patients might cause the progression of fibrosis and shorter survival. 24 Results of the present study confirm that TGF-β 1 in BAL fluid may be a good but not specific marker of fibrosis in DPLDs. A significant positive correlation between TGF-β 1 levels in BAL fluid and the activity assessed by HRCT score was observed.
rEfErEncEs
The final analysis was performed in 28 patients who showed nonhomogenous distribution of changes on HRCT.
In the GD group, TGF-β 1 levels in sA were 4.4 ±3.6 pg/ml, while in sB -3.4 ±2.3 pg/ml. In the IIP group, TGF-β 1 levels were 9.0 ±8.6 pg/ml and 4.7 ±3.3 pg/ml in sA and sB, respectively. The TGF-β 1 levels in BAL fluid were significantly higher in the areas with high activity of changes estimated by HRCT score (P = 0.018, ANOVA). TGF-β 1 levels in BAL fluid were not different between the groups, but a trend towards higher levels in the IIP group was observed (fIGurE 1). dIscussIon The diagnosis of DPLDs is usually based on radio logical findings, but even such a reliable method as HRCT has some limitations. Its accuracy in the diagnosis of IPF varies from 50% to 90% 10 -13 and largely depends on the experience of a radio logist.
However, in some cases, histo logical confirmation is necessary and VATS lung bio psy might be required. Open lung bio psy can determine the diagnosis in patients with DPLD in 70% to 93% of cases.
14 In our study, histo logical examination of VATS lung specimen allowed to establish a definitive diagnosis in 83.9% of patients, but the final diagnosis of DPLD, based on clinical features, radio logical findings, and histopatho logic results, was established in all patients.
A technique that is suggested to increase the diagnostic yield of HRCT is the semiquantitative HRCT score. Its advantage is the quantitative assessment of the types of opacities and their activity. The use of HRCT score gives a unique opportunity to assess correlations between TGF-β 1 levels in BAL fluid in DPLD patients and the radiological activity of changes. Until now, there have been no data assessing the association between HRCT score and profibrotic TGF-β 1 .
Based on the HRCT score, our data have shown that TGF-β 1 levels in all patients were significantly higher in the areas with high disease activity ArtyKuŁ oryGInALny TGF-β 1 w popłuczynach oskrzelowo--pęcherzykowych u chorych na śród miąższowe choroby płuc a aktywność zmian w tomografii komputerowej o wysokiej rozdzielczości
